BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 26411097)

  • 1. MUCINOUS ADENOCARCINOMA OVARY: DIAGNOSTIC DILEMMA AND THE USEFULNESS OF COLONOSCOPY.
    Mehmood S; Khan MQ
    J Ayub Med Coll Abbottabad; 2015; 27(2):280-3. PubMed ID: 26411097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pathologic distinction of primary and metastatic mucinous tumors involving the ovary: A re-evaluation of algorithms based on gross features.
    Hu J; Khalifa RD; Roma AA; Fadare O
    Ann Diagn Pathol; 2018 Dec; 37():1-6. PubMed ID: 30179792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary and metastatic mucinous adenocarcinomas of the ovary: Evaluation of the diagnostic approach using tumor size and laterality.
    Khunamornpong S; Suprasert P; Pojchamarnwiputh S; Na Chiangmai W; Settakorn J; Siriaunkgul S
    Gynecol Oncol; 2006 Apr; 101(1):152-7. PubMed ID: 16300822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathology of primary and metastatic mucinous ovarian neoplasms.
    Leen SL; Singh N
    J Clin Pathol; 2012 Jul; 65(7):591-5. PubMed ID: 22075188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemistry in the Diagnosis of Mucinous Neoplasms Involving the Ovary: The Added Value of SATB2 and Biomarker Discovery Through Protein Expression Database Mining.
    Strickland S; Wasserman JK; Giassi A; Djordjevic B; Parra-Herran C
    Int J Gynecol Pathol; 2016 May; 35(3):191-208. PubMed ID: 26535987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinction of primary and metastatic mucinous tumors involving the ovary: analysis of size and laterality data by primary site with reevaluation of an algorithm for tumor classification.
    Yemelyanova AV; Vang R; Judson K; Wu LS; Ronnett BM
    Am J Surg Pathol; 2008 Jan; 32(1):128-38. PubMed ID: 18162780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas.
    Vang R; Gown AM; Farinola M; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Judson K; Ronnett BM
    Am J Surg Pathol; 2007 May; 31(5):653-63. PubMed ID: 17460447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical characterization of appendiceal mucinous neoplasms and the value of special AT-rich sequence-binding protein 2 in their distinction from primary ovarian mucinous tumours.
    Strickland S; Parra-Herran C
    Histopathology; 2016 Jun; 68(7):977-87. PubMed ID: 26542609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel algorithm for better distinction of primary mucinous ovarian carcinomas and mucinous carcinomas metastatic to the ovary.
    Simons M; Bolhuis T; De Haan AF; Bruggink AH; Bulten J; Massuger LF; Nagtegaal ID
    Virchows Arch; 2019 Mar; 474(3):289-296. PubMed ID: 30631934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diversity in size and signal intensity in multilocular cystic ovarian masses: new parameters for distinguishing metastatic from primary mucinous ovarian neoplasms.
    Tanaka YO; Okada S; Satoh T; Matsumoto K; Oki A; Saida T; Yoshikawa H; Minami M
    J Magn Reson Imaging; 2013 Oct; 38(4):794-801. PubMed ID: 23440747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastatic mucinous carcinomas in the ovary: a practical approach to diagnosis related to gross aspects and to immunohistochemical evaluation.
    Pinto PB; Derchain SF; Andrade LA
    Int J Gynecol Pathol; 2012 Jul; 31(4):313-8. PubMed ID: 22653343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemistry in the distinction between primary and metastatic ovarian mucinous neoplasms.
    McCluggage WG
    J Clin Pathol; 2012 Jul; 65(7):596-600. PubMed ID: 21768188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early stage primary ovarian mucinous carcinoma: Outcome-based clinicopathological study in comparison with serous carcinoma.
    Tian Q; Lu B; Ye J; Lu W; Xie X; Wang X
    J Int Med Res; 2016 Apr; 44(2):357-66. PubMed ID: 26880793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum CA19.9 levels are commonly elevated in primary ovarian mucinous tumours but cannot be used to predict the histological subtype.
    Kelly PJ; Archbold P; Price JH; Cardwell C; McCluggage WG
    J Clin Pathol; 2010 Feb; 63(2):169-73. PubMed ID: 20154039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiating primary and extragenital metastatic mucinous ovarian tumours: an algorithm combining PAX8 with tumour size and laterality.
    Hu A; Li H; Zhang L; Ren C; Wang Y; Liu Y; Liu C
    J Clin Pathol; 2015 Jul; 68(7):522-8. PubMed ID: 25827135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucinous adenocarcinoma involving the ovary: comparative evaluation of the classification algorithms using tumor size and laterality.
    Jung ES; Bae JH; Lee A; Choi YJ; Park JS; Lee KY
    J Korean Med Sci; 2010 Feb; 25(2):220-5. PubMed ID: 20119573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucinous carcinoma of thyroid gland. Report of a primary and a metastatic mucinous tumour from ovarian adenocarcinoma with immunohistochemical study and review of literature.
    D'Antonio A; Addesso M; De Dominicis G; Boscaino A; Liguori G; Nappi O
    Virchows Arch; 2007 Oct; 451(4):847-51. PubMed ID: 17704943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Women with undiagnosed colorectal adenocarcinomas presenting with ovarian metastases: clinicopathologic features and comparison with women having known colorectal adenocarcinomas and ovarian involvement.
    Judson K; McCormick C; Vang R; Yemelyanova AV; Wu LS; Bristow RE; Ronnett BM
    Int J Gynecol Pathol; 2008 Apr; 27(2):182-90. PubMed ID: 18317225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of SATB2 in the differential diagnosis of intestinal-type mucinous tumors of the ovary: primary vs metastatic.
    Perez Montiel D; Arispe Angulo K; Cantú-de León D; Bornstein Quevedo L; Chanona Vilchis J; Herrera Montalvo L
    Ann Diagn Pathol; 2015 Aug; 19(4):249-52. PubMed ID: 26059401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of mesothelin, fascin, and prostate stem cell antigen in primary ovarian mucinous tumors and their utility in differentiating primary ovarian mucinous tumors from metastatic pancreatic mucinous carcinomas in the ovary.
    Cao D; Ji H; Ronnett BM
    Int J Gynecol Pathol; 2005 Jan; 24(1):67-72. PubMed ID: 15626919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.